Financials · mywealthgrid

Consolidated figures · ₹ crore

₹ Cr	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	7,219	7,352	7,580	7,567	7,796	7,979	8,382	7,868	8,286	8,646	8,853	9,150
COGS	3,237	3,151	3,061	3,073	3,210	3,315	3,428	3,239	3,339	3,481	3,429	3,627
Gross profit	3,983	4,201	4,519	4,494	4,586	4,663	4,954	4,629	4,947	5,165	5,424	5,523
	2,608	2,602	2,859	2,876	3,019	3,084	3,195	3,024	3,267	3,391	3,674	3,644
	1,374	1,599	1,660	1,618	1,566	1,580	1,760	1,605	1,680	1,774	1,750	1,880
OPM %	19%	21.8%	21.9%	21.4%	20.1%	19.8%	21%	20.4%	20.3%	20.5%	19.8%	20.5%
Depreciation	418	423	354	404	382	419	444	406	429	465	479	487
Interest	68	76	89	111	113	118	115	98	95	93	98	102
	187	163	14	221	136	157	135	105	121	122	117	224
Profit before tax	1,076	1,262	1,230	1,324	1,207	1,200	1,335	1,207	1,276	1,339	1,291	1,515
Tax	324	322	323	406	391	354	432	383	428	429	370	483
Tax %	30.1%	25.5%	26.2%	30.6%	32.3%	29.5%	32.4%	31.7%	33.5%	32%	28.7%	31.9%
	752	940	907	918	817	846	903	824	848	910	921	1,032
PAT margin %	10.4%	12.8%	12%	12.1%	10.5%	10.6%	10.8%	10.5%	10.2%	10.5%	10.4%	11.3%
EPS (₹)	12.8	16	15.5	15.7	14	14.6	15.6	14.2	14.6	15.7	15.9	17.9
Results filing	—	—	—	—	—	—	—	—	—	Results filing for Dec 2025	Results filing for Mar 2026	—

vs same quarter last year	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue YoY %	+25.8%	+14.7%	+17.1%	+10.5%	+8%	+8.5%	+10.6%	+4%

Aurobindo Pharma Limited